Specifications - Novartis Vaccine Manufacturing Facility, North Carolina, USA

Key Data
Order Year	2006
Location	Holly Springs, North Carolina
Estimated Investment	$600m
Completion	2008 in production by 2011
Output Chemicals	Flu vaccines
Key Players
Sponsor	Novartis
Contractors	Jacobs Engineering Group
Financing	Novartis, State of North Carolina, City of Holly Springs, Golden LEAF Foundation, US Department of Health and Human Services